Standard Operating Procedure for CMC Readiness Assessment for Filing Milestones
| Department | Regulatory Affairs |
| SOP No. | RA/2026/723 |
| Supersedes | NA |
| Page No. | 1 of X |
| Issue Date | 14/04/2026 |
| Effective Date | 14/04/2026 |
| Review Date | 14/04/2028 |
Purpose
This Standard Operating Procedure (SOP) establishes a consistent and controlled process for assessing the readiness of Chemistry, Manufacturing, and Controls (CMC) documentation and associated activities to meet filing milestones for regulatory submissions. The SOP ensures compliance with regulatory requirements, supports timely submission, and mitigates risks related to incomplete or non-compliant dossiers, thereby facilitating successful regulatory approvals.
Scope
This SOP applies to all CMC-related activities within Regulatory Affairs, Quality Systems, Manufacturing, Quality Control, Analytical Development, and Documentation Management departments involved in preparing, reviewing, verifying, and finalizing CMC documentation for regulatory filings. It covers all dosage forms and product types intended for submission to health authorities. Activities outside CMC dossier readiness, such as clinical data review or post-approval change submissions, are excluded.
Responsibilities
- Regulatory Affairs Associates: Execute and document readiness assessments, coordinate with cross-functional teams.
- Quality Assurance: Review and verify compliance of CMC documentation and process readiness.
- Manufacturing and QC Teams: Provide status updates and data supporting CMC documentation.
- Document Control: Ensure control and versioning of CMC dossiers and related documents.
- Regulatory Affairs Manager: Oversee the assessment process and endorse readiness reports.
Accountability
The Regulatory Affairs Head is accountable for ensuring implementation, compliance, and periodic review of this SOP. They are responsible for escalation of issues impacting filing milestones, ensuring corrective actions, and maintaining overall effectiveness of the CMC readiness assessment process.
Procedure
The CMC Readiness Assessment for Filing Milestones shall be conducted through the following stages:
1. Preparation and Prerequisites: Prior to assessment, assemble all relevant CMC documentation, including but not limited to analytical validation reports, batch manufacturing records, stability data, validation protocols, and summary documents. Ensure document control system contains the latest approved versions.
2. Team Coordination: Convene a cross-functional team comprising Regulatory Affairs, QA, Manufacturing, QC, and Documentation representatives. Schedule readiness meetings aligned with the filing timeline.
3. Assessment Execution: Conduct a comprehensive review of documentation completeness, adherence to regulatory guidelines, and alignment with filing requirements. Verify that manufacturing processes, validation and qualification activities, and analytical methods are validated and documented appropriately.
Evaluate the status of stability data against required timelines and product shelf-life claims. Confirm that all deviations, investigations, and change controls related to the dossier components are closed or adequately justified.
4. In-process Controls and Verification: Cross-check all documentation against established checklists and acceptance criteria reflective of regulatory authority expectations. Assess data integrity and compliance with GMP standards. Identify any gaps or pending activities that may jeopardize filing readiness.
5. Documentation and Reporting: Compile a formal readiness assessment report summarizing findings, gaps, and recommended corrective actions. Present the report to senior management and obtain required approvals.
6. Deviations and Approvals: If significant deficiencies are identified, initiate deviation reports and corrective action plans. Monitor implementation of corrective measures and perform follow-up assessments as necessary.
7. Record Retention and Closure: Archive all readiness assessment reports, supporting data, meeting minutes, and approvals in accordance with document retention policies. Ensure records are easily retrievable for audits and inspections.
By following this structured approach, organizations can ensure comprehensive readiness for CMC dossier filings, meet regulatory expectations, minimize submission delays, and uphold product quality and compliance.
Abbreviations
- CMC – Chemistry, Manufacturing, and Controls
- GMP – Good Manufacturing Practice
- QA – Quality Assurance
- QC – Quality Control
- RA – Regulatory Affairs
- SOP – Standard Operating Procedure
- RMS – Regulatory Management System
Documents
The following documents are required for the CMC readiness assessment process:
- CMC Readiness Assessment Checklist (Annexure-1)
- CMC Readiness Assessment Report Template (Annexure-2)
- Corrective Action and Preventive Action (CAPA) Tracking Log (Annexure-3)
References
- ICH Q7: Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients
- ICH Q10: Pharmaceutical Quality System
- FDA Guidance for Industry: Content and Format of Chemistry, Manufacturing, and Controls Information
- EU GMP Guidelines Part I and Annexes
- Internal Quality Management System Documentation
Version
1.0
Approval
| Prepared By | |
| Checked By | |
| Approved By |
Annexures
Annexure-1: CMC Readiness Assessment Checklist
Purpose: To systematically verify the completeness and compliance status of all CMC documentation and activities supporting the filing milestone.
| Section | Item | Status (Y/N/NA) | Comments |
|---|---|---|---|
| Documentation | Approved batch manufacturing records | Y | Completed and signed |
| Validation | Process validation reports available | Y | All reports finalized |
| Stability | Stability data meets regulatory requirements | N | Additional 3 months data pending |
| Analytical Methods | Validated analytical methods documented | Y | Validated per ICH Q2 guidelines |
| Deviations | All deviations closed or justified | Y | No open critical deviations |
Annexure-2: CMC Readiness Assessment Report Template
Purpose: To document the outcome of the readiness assessment, highlight gaps, corrective actions required, and provide a formal endorsement of filing preparedness.
| Report Title: | CMC Readiness Assessment Report for Filing Milestone |
| Product Name: | Example Product X |
| Filing Milestone Date: | 30/06/2026 |
| Assessment Date: | 15/04/2026 |
| Prepared By: | |
| Reviewed By: | |
| Approval Status: | Pending / Approved |
| Summary of Findings: – All critical documentation complete except pending stability data – Validation documentation complete and approved – Deviations closed – No data integrity issues identified |
|
| Corrective Actions Required: – Expedite additional stability data collection – Monitor CAPA implementation status |
|
| Comments: – Follow-up assessment scheduled for 30/05/2026 – Filing milestone achievable with timely closure of actions |
|
Annexure-3: Corrective Action and Preventive Action (CAPA) Tracking Log
Purpose: To track CAPA related to CMC readiness assessment findings until closure and compliance verification.
| CAPA Number | Description | Assigned To | Target Completion Date | Status | Comments |
|---|---|---|---|---|---|
| CAPA-2026-01 | Complete pending stability data | Stability Department | 25/05/2026 | Open | Tracking accelerated sample testing |
| CAPA-2026-02 | Update document control records | Document Control Team | 20/04/2026 | Closed | Completed on schedule |
Revision History
| Revision Date | Revision No. | Revision Details | Reason for Revision | Approved By |
| 14/04/2026 | 1.0 | Initial issue | New SOP creation |